Vir Biotechnology, Inc. (VIR) stock analysis
VIR · Vir Biotechnology, Inc.
Latest recorded price: USD 9.58
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth -65.1%, free cash flow margin -578.5%, ROIC -121.9%. The model flags 3 risk signals for this company (2 high severity).